Skip to main content
Log in

Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

We evaluated the efficacy of long-term cyclosporin A (CyA) treatment in the maintenance of remission in 40 children with steroid-dependent minimal-change nephrotic syndrome (MCNS). CyA was given in an initial dose of 5 mg/kg per day, adjusted to maintain a trough whole blood level of 50–150 ng/ml. All the 40 children received CyA for 1 year. In 18 patients, CyA was continued for a further period of at least a year without interruption; 9 patients had a second course of CyA therapy after an interval of at least 1 month. Of the 40 children 29 (72%) had one or more relapses during treatment with CyA, with 16 (40%) relapsing during the 1st year. During the second period of CyA, 10 (56%) of the 18 children treated continuously relapsed, whereas all the 9 children who had an interrupted course of therapy relapsed. CyA was discontinued at one time in 27 patients, all of whom subsequently relapsed, with a median time to relapse of 26 days. Long-term prednisolone in addition to CyA was required to maintain remission in 16 (40%) of the whole group. The results suggest that the long-term use of CyA is able to maintain remission of MCNS, although 40% of the patients also required low-dose alternate-day steroids; patients appeared to fare worse if the CyA course was interrupted; no patient experienced a long-term remission after CyA was stopped.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brodehl J (1991) The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 150: 380–387

    Google Scholar 

  2. Meyrier A, Collaborative Group of the Société de Néphrologie (1989) Ciclosporin in the treatment of nephrosis. Am J Nephrol 9 [Suppl 1]: 65–71

    Google Scholar 

  3. Myerier A, Simon P, Perret G, Condamin-Meyrier M-C (1986) Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. BMJ 292: 789–792

    Google Scholar 

  4. Niaudet P, Broyer M, Habib R (1991) Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 35 [Suppl 1]: 31–36

    Google Scholar 

  5. Brodehl J, Hoyer PF, Oemar BS, Helmchen U, Wonigeit K (1988) Cyclosporine treatment of nephrotic syndrome in children Transplant Proc 20 [Suppl 4]: 269–274

    Google Scholar 

  6. Capodicasa G, De Santo NG, Nuzzi F, Giordano C (1986) Cyclosporin A in nephrotic syndrome of childhood — a 14 month experience. Int J Pediatr Nephrol 7: 69–72

    Google Scholar 

  7. Niaudet P, French Society of Paediatric Nephrology (1992) Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Pediatr Nephrol 6: 1–3

    Google Scholar 

  8. Tejani A, Suthanthiran M, Pomrantz A (1991) A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron 59: 96–99

    Google Scholar 

  9. Kitano Y, Yoshikawa N, Tanaka R, Nakamura H, Nimomiya M, Ito H (1990) Cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 4: 474–477

    Google Scholar 

  10. Hulton S-A, Jadresic L, Shah V, Trompeter RS, Dillon MJ, Barratt TM (1994) Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome. Pediatr Nephrol (in press)

  11. Barratt TM (1979) Nephrotic syndrome. In: Valman HB (ed) Paediatric therapeutics. Blackwell, Oxford, pp 81–98

    Google Scholar 

  12. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal J, Khawar MR (1987) Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J Pediatr 111: 1056–1062

    Google Scholar 

  13. Neuhaus TJ, Burger HR, Klinger M, Fanconi A, Leumann EP (1992) Long-term low-dose cyclosporin A in steroid-dependent nephrotic syndrome of childhood. Eur J Pediatr 151: 775–778

    Google Scholar 

  14. Melocoton TL, Kamil ES, Cohen AH, Fine RN (1991) Long-term cyclosporine-A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 18: 583–588

    Google Scholar 

  15. Borel JF (1991) Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome. Clin Nephrol 35 [Suppl 1]: 23–30

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hulton, SA., Neuhaus, T.J., Dillon, M.J. et al. Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood. Pediatr Nephrol 8, 401–403 (1994). https://doi.org/10.1007/BF00856511

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00856511

Key words

Navigation